Cleared Traditional

K983073 - I.V. EXTENSION SET OR I.V. ADMINISTRATION SET

K983073 is an FDA 510(k) clearance for I.V. EXTENSION SET OR I.V. ADMINISTRATI..., manufactured by Integra Biotechnical, LLC. The device is a Class 2 General Hospital device with product code FPA cleared through the Traditional 510(k) pathway after a 105-day FDA review.

K983073 · Integra Biotechnical, LLC · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1998
Decision
105d
Days
Class 2
Risk

K983073 is an FDA 510(k) clearance for the I.V. EXTENSION SET OR I.V. ADMINISTRATION SET. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Integra Biotechnical, LLC (Oceanside, US). The FDA issued a Cleared decision on December 16, 1998 after a review of 105 days - within the typical 510(k) review window.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Integra Biotechnical, LLC devices

FDA 510(k) Submission Details - K983073

510(k) Number K983073 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 02, 1998
Decision Date December 16, 1998
Days to Decision 105 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
24d faster than avg
Panel avg: 129d · This submission: 105d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 681
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K983073.
SUBCUTANEOUS INFUSION SETS, MSR MODEL A & B
K984561 · Msr, Inc. · Feb 1999
ROWE DUAL-CHECK VALVE
K983217 · Cook, Inc. · Jan 1999
MPS GRAVITY FLOW CONTROL SET
K983926 · Critical Device Corp. · Jan 1999
COLLEAGUE PUMP SYRINGE ADAPTER SET
K982672 · Baxter Healthcare Corp · Sep 1998
MPS FIXED FLOW RATE SET
K982587 · Medical Product Specialists · Aug 1998
SOLUTION ADMINISTRATION SET
K981792 · Baxter Healthcare Corp · Aug 1998